All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0711 | Anti-DYNC1LI1 (1B9) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 1B9 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0712 | Anti-DYNC1LI1 (1C2) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 1C2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0713 | Anti-DYNC1LI1 (1C5) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 1C5 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0714 | Anti-DYNC1LI1 (1D1) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 1D1 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0715 | Anti-DYNC1LI1 (1G9) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 1G9 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0716 | Anti-DYNC1LI1 (1H4) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 1H4 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0717 | Anti-DYNC1LI1 (2B6) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 2B6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0718 | Anti-DYNC1LI1 (2E8) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 2E8 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1611 | Anti-DYNC1LI1 (1B9) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 1B9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1612 | Anti-DYNC1LI1 (1C2) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 1C2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1613 | Anti-DYNC1LI1 (1C5) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 1C5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1614 | Anti-DYNC1LI1 (1D1) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 1D1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1615 | Anti-DYNC1LI1 (1G9) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 1G9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1616 | Anti-DYNC1LI1 (1H4) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 1H4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1617 | Anti-DYNC1LI1 (2B6) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 2B6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1618 | Anti-DYNC1LI1 (2E8) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 2E8 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3066 | Anti-DYNC1LI1 (CBFYC-2597) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2597 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6319 | Anti-DYNC1LI1 (CBFYC-2597) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2597 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION